card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Leveraging Genomics-Based Assays for Immuno-Oncology in Clinical Research

Molecular Medicine Tri-Conference 2017
Home / Insights / Leveraging Genomics-Based Assays for Immuno-Oncology in Clinical Research

Presented at Molecular Medicine Tri-Conference 2017, this presentation provides an overview of how genomics-based assays can be effectively implemented for immuno-oncology clinical research. With the expansion of immuno-oncology pipelines over the last decade, genomics-based assays can help design and execute smarter trials. Self-recognition HLA and KIR typing, immune gene signature, and tumor characterization can be used to develop "virtual panels" of expression targets to recapitulate IO targeted panels, identify neo-antigens directly from RNA sequencing data, and more. 

Download this presentation to learn more. IQVIA Laboratories offers a range of genomic services to support drug discovery, precision medicine and clinical development. Our industry-leading genomic services team can help you uncover valuable insights from your genomic data. Through carefully orchestrated analyses, we work with you to choose platforms and assays that will distinctly fit your needs, and then use them to deliver valuable, informative data.

Speaker:
Victor Weigman, Ph.D., Director, Translational Genomics